Bank of New York Mellon’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$163M Sell
491,200
-12,933
-3% -$4.4M 0.03% 452
2025
Q4
$200M Buy
504,133
+84,350
+20% +$37.3M 0.04% 376
2025
Q3
$191M Sell
419,783
-9,986
-2% -$4.07M 0.03% 388
2025
Q2
$140M Sell
429,769
-45,063
-9% -$12.5M 0.03% 474
2025
Q1
$128M Sell
474,832
-4,371
-0.9% -$1.12M 0.03% 515
2024
Q4
$113M Buy
479,203
+4,764
+1% +$1.25M 0.02% 588
2024
Q3
$130M Sell
474,439
-199,263
-30% -$51.9M 0.02% 524
2024
Q2
$164M Sell
673,702
-124,743
-16% -$19.7M 0.03% 435
2024
Q1
$119M Sell
798,445
-38,686
-5% -$6.45M 0.02% 571
2023
Q4
$160M Buy
837,131
+47
+0% +$8.01K 0.03% 448
2023
Q3
$148M Buy
837,084
+61,488
+8% +$11.7M 0.03% 441
2023
Q2
$147M Buy
775,596
+221,259
+40% +$43.9M 0.03% 468
2023
Q1
$111M Sell
554,337
-20,048
-3% -$4.21M 0.02% 575
2022
Q4
$137M Buy
574,385
+7,247
+1% +$1.55M 0.03% 484
2022
Q3
$114M Sell
567,138
-108,017
-16% -$20.6M 0.03% 541
2022
Q2
$98.5M Buy
675,155
+36,287
+6% +$5.15M 0.02% 606
2022
Q1
$104M Buy
638,868
+36,554
+6% +$5.57M 0.02% 650
2021
Q4
$102M Buy
602,314
+149,064
+33% +$27.7M 0.02% 694
2021
Q3
$85.6M Buy
453,250
+11,249
+3% +$2.11M 0.02% 767
2021
Q2
$74.9M Buy
442,001
+20,187
+5% +$2.96M 0.01% 876
2021
Q1
$59.6M Sell
421,814
-20,874
-5% -$3.14M 0.01% 990
2020
Q4
$57.5M Buy
442,688
+7,733
+2% +$1.03M 0.01% 962
2020
Q3
$63.3M Buy
434,955
+180
+0% +$25.6K 0.02% 778
2020
Q2
$64.4M Sell
434,775
-8,489
-2% -$1.14M 0.02% 744
2020
Q1
$48.2M Buy
443,264
+1,121
+0.3% +$129K 0.02% 773
2019
Q4
$50.9M Sell
442,143
-8,560
-2% -$853K 0.01% 965
2019
Q3
$36.2M Buy
450,703
+50,010
+12% +$3.96M 0.01% 1149
2019
Q2
$29.1M Buy
400,693
+10,495
+3% +$805K 0.01% 1315
2019
Q1
$36.5M Sell
390,198
-105,795
-21% -$8.85M 0.01% 1171
2018
Q4
$36.2M Sell
495,993
-16,177
-3% -$1.24M 0.01% 1098
2018
Q3
$44.8M Buy
512,170
+209
+0% +$21K 0.01% 1104
2018
Q2
$50.4M Buy
511,961
+113,650
+29% +$11.3M 0.01% 1001
2018
Q1
$47.4M Buy
398,311
+3,044
+0.8% +$392K 0.01% 1042
2017
Q4
$50.2M Buy
395,267
+53,162
+16% +$6.68M 0.01% 1012
2017
Q3
$40.2M Buy
342,105
+8,163
+2% +$697K 0.01% 1120
2017
Q2
$26.6M Buy
333,942
+28,260
+9% +$1.81M 0.01% 1365
2017
Q1
$15.7M Buy
305,682
+2,899
+1% +$134K ﹤0.01% 1692
2016
Q4
$11.3M Sell
302,783
-23,779
-7% -$996K ﹤0.01% 1894
2016
Q3
$22.1M Sell
326,562
-22,074
-6% -$1.56M 0.01% 1399
2016
Q2
$19.3M Buy
348,636
+30,960
+10% +$1.95M 0.01% 1424
2016
Q1
$19.9M Buy
317,676
+5,625
+2% +$374K 0.01% 1410
2015
Q4
$29.4M Sell
312,051
-7,223
-2% -$670K 0.01% 1139
2015
Q3
$25.7M Buy
319,274
+6,465
+2% +$718K 0.01% 1243
2015
Q2
$37.5M Buy
312,809
+14,024
+5% +$1.68M 0.01% 1070
2015
Q1
$31.2M Buy
298,785
+32,466
+12% +$3.29M 0.01% 1185
2014
Q4
$25.8M Sell
266,319
-2,906
-1% -$269K 0.01% 1282
2014
Q3
$21M Buy
269,225
+2,337
+0.9% +$151K 0.01% 1395
2014
Q2
$16.9M Sell
266,888
-69,062
-21% -$4.1M ﹤0.01% 1599
2014
Q1
$22.6M Buy
335,950
+746
+0.2% +$57.8K 0.01% 1375
2013
Q4
$21.6M Sell
335,204
-180,120
-35% -$10.7M 0.01% 1408
2013
Q3
$33M Sell
515,324
-52,266
-9% -$2.61M 0.01% 1100
2013
Q2
$17.6M Buy
+567,590
New +$15.1M 0.01% 1460

Other funds holding ALNY